Clinical

Dataset Information

0

Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer Patients


ABSTRACT: This study makes an observation over the objective response rate of Apatinib and 5-Fu combination regimen in the three-line treatment of metastatic colorectal cancer. All the participants will randomly receive the treatment of Apatinib and 5-Fu combination regimen or 5-Fu.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2248748 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2219525 | ecrin-mdr-crc
2021-11-03 | GSE185783 | GEO
2019-05-15 | GSE129221 | GEO
| PRJNA756936 | ENA
2020-12-30 | GSE89531 | GEO
| PRJNA797915 | ENA
2015-06-03 | GSE69494 | GEO
| EGAS00001003592 | EGA
2021-02-10 | GSE157950 | GEO
2021-02-10 | GSE157949 | GEO